NEW YORK, March 25 - Agencourt Bioscience on Monday said that the Duke University Medical Center has picked its Solid Phase Reversible Immobilization technology to help its cancer research.

The deal, funded by the National Cancer Institute's Cancer Genome Anatomy Project, will give researchers at Duke's Brain Cancer Genomics Laboratory access to Agencourt's SPRI technology to help them determine the molecular anatomy of normal, pre-cancer, and cancer cells. Terms also call for Agencourt to sequence Duke's SAGE libraries.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.